A cluster randomised, controlled trial evaluating a novel Holistic Approach in Primary care for PreventIng Memory Impairment aNd Dementia (HAPPI MIND) intervention aimed at assessing and reducing dementia risk factors as measured using the Australian National University - Alzheimer's Disease Risk Index (ANU-ADRI)

Monash University0 个研究点目标入组 403 人开始时间: 2021年8月30日最近更新: 2024年4月22日

适应症

试验速览

暂无简介。

•Community-dwelling adults, aged 45-65years, with two or more modifiable risk factors for dementia who have access to, and are able to use, a smartphone, and who have had at least one visit to the practice/clinic in the previous 12 months, will be eligible. One or more visits will indicate patient engagement with the practice/clinic.
•Modifiable risk factors include: high blood pressure, hyperlipidaemia, type 2 diabetes, obesity, current smoking, physical inactivity, poor diet, excessive drinking of alcohol, depression, social isolation and lack of cognitive stimulation.

•Patients who are unable to provide informed consent, those unable to communicate in English, those with a terminal illness (anticipated survival <36 months) or those with other conditions preventing participation in the study as judged by the GP or their nominee will be excluded. Patients with a history of existing dementia, cognitive impairment or other significant neurologic disease (e.g. Parkinson’s disease, Huntington’s disease, multiple sclerosis, normal pressure hydrocephalus, progressive supranuclear palsy, seizure disorder, subdural hematoma, or history of significant head trauma with persistent neurologic sequelae or known structural brain abnormalities) will be excluded. Patients who are involved in other clinical trials targeting any of the modifiable risk factors for dementia listed above will be excluded.

发起方